# Independent Claude strategy review — complete, conditional pass

September 20, 2026.

The user explicitly requested [claude-strategy-review](/Users/dgrissen/Dev/persona-review-kit/skills/claude-strategy-review/SKILL.md). Its instructions were read. The skill specifies an independent Claude Opus 5 review with xhigh effort and tools enabled.

The original side conversation prohibited separate reviewer agents, so it saved
this request without launching or queuing a review. On September 20 the user
explicitly requested execution in the main conversation. The review was launched
at 11:45:45 UTC using Claude Opus5, xhigh effort, default tools and auto permission
mode, through the requested skill. It completed in 451 seconds with FAIL and 12 findings. The author assessed every finding in REVIEW_RESPONSE.md, amended the proposal, and retained the unedited original and review. The focused independent recheck completed in 523 seconds with CONDITIONAL PASS and seven findings. The author then narrowed claims and added explicit coverage, sparse-result and overlap conditions; those final edits have not received a third review.

Actual run artifacts:
`/Users/dgrissen/.cache/agent-review-runs/20260920T114545Z-claude-strategy-review-generic-strategy-review-37643`.
Project output: `CLAUDE_STRATEGY_REVIEW.md`; live progress:
`claude_review_progress.log`. The existing Charlie text remains author framing,
not an independent review. The concurrently running SPX data backfill is separate
from strategy outcome testing; see REVIEW_EXECUTION_CONTEXT.md.

## Concrete review request

Review [CHARLIE_PROPOSAL.md](/Users/dgrissen/Dev/delta_bomb/outputs/b09_mad_followup_plan_2026-09-20/CHARLIE_PROPOSAL.md) as the author's proposed plan. Check whether it credibly pursues a balance of +5-before−10 hit rate and retained opportunities across half-years, while containing additional search after the completed 48-cell B09 study.

Use a generic independent strategy/logic review. Inspect primary data and source code as needed; do not use prior persona verdicts or review conclusions as evidence. The proposal's persona interpretation is author framing, not a review result to agree with.

Specific questions:

1. Do B07 and B05 have a coherent transfer hypothesis, and is choosing B05 over the older B03 challenger adequately justified without pretending this choice was predeclared before all earlier research?
2. Is the four-primary-cell budget, plus six explicitly named sign controls (including two on B09 first), bounded enough? Are there undisclosed extra comparisons or choices that could make the result an optimizer in disguise?
3. Are the population, causal above-VT rule, T−1 information clock, native-minute +5/−10 outcome, missingness, and filter-before-spacing policies consistent? Could any proposed comparison condition on future information?
4. Do the claims properly distinguish larger parent N, retained N, active dates, unique opportunities, and overlapping signals? Does the report keep weak partial 2026 H2 results and all unknown groups visible?
5. Is the proposed 30-day ATM SPXW construction actually comparable to the ETF feature? What contract, quote-quality, model, source-time, or interpolation assumptions must be verified first?
6. Does the SPX/sector disagreement test isolate useful incremental entries? Could the OR comparison merely recover missing coverage, change the population, or reduce accuracy while raising N?
7. Do the same-clock sign controls test whether MAD magnitude adds value? Are any conclusions stronger than the evidence permits after 48 correlated cells and repeated use of the same dates?
8. What specific changes, if any, are needed before this plan should be executed? Give evidence-based blocking concerns and separate them from optional extensions. Do not expand to a full B0x/threshold/tenor sweep.

## Primary context to inspect

- [Completed B09 findings](/Users/dgrissen/Dev/delta_bomb/outputs/b09_mad_grid_2026-09-19/FINDINGS.md).
- [All 48 cells](/Users/dgrissen/Dev/delta_bomb/outputs/b09_mad_grid_2026-09-19/ALL_48_RESULTS.md).
- [Frozen B09 protocol](/Users/dgrissen/Dev/delta_bomb/outputs/b09_mad_grid_2026-09-19/PROTOCOL.md).
- [Summary data](/Users/dgrissen/Dev/central_trade_data/thetadata/b09_mad_grid_2026-09-19-v1/summary.csv) and [uncertainty data](/Users/dgrissen/Dev/central_trade_data/thetadata/b09_mad_grid_2026-09-19-v1/uncertainty.csv).
- [Existing parent comparisons](/Users/dgrissen/Dev/central_trade_data/thetadata/branch_b_iv_full_2024_2026_2026-09-19-v1/comparison.csv).
- Exact parent source paths and SPX source inventory listed in the proposal.

Both reviews completed successfully as tool runs; their strategy verdicts differ because the proposal was revised. The original FAIL is preserved. The latest independent verdict is CONDITIONAL PASS for exploratory research, not unconditional sign-off or evidence of a trading edge.

Recheck artifacts:
`/Users/dgrissen/.cache/agent-review-runs/20260920T120210Z-claude-strategy-review-generic-strategy-review-41677`.
Output: `CLAUDE_STRATEGY_RECHECK.md`.

The reviewer reproduced two proposed B09 control outcomes despite the explicit
no-new-tests scope. They are disclosed as already inspected. No formal B07/B05
transfer or SPX outcome study was run. The separate SPX measurement collection
has now completed; see the final proposal’s post-review readiness update. REVIEW_RESPONSE.md and the final proposal record which
conditions were accepted, which claims were narrowed, and which optional cells
were deferred.
